JAVIER
PUENTE VÁZQUEZ
Profesor asociado de Ciencias de la Salud
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von University of Texas MD Anderson Cancer Center (2)
2024
2017
-
Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer
Journal of Clinical Oncology, Vol. 35, Núm. 1, pp. 40-47